Project Grant R01DA059293
Award Date 7/15/24
Completion Date 4/30/25
Dollars Obligated $912K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded $877,500 to the University of California, San Diego for a two-year project (July 15, 2025 through June 30, 2027) investigating neurobiological mechanisms underlying cocaine use disorder (CUD) susceptibility. The project employs a novel polygenic prediction methodology called RATTACA to identify pre-existing cellular differences in gabaergic and...
- Grant Award Summary Duke University received a $1.74 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded September 30, 2025, with completion targeted for May 31, 2030. The research initiative, titled "Dissecting and Modulating Cell Type and Circuit-Specific Epigenetic Mechanisms of Cocaine Addiction," will investigate the molecular and cellular mechanisms underlying cocaine addiction through...
- This $1.59 million Project Grant, awarded September 1, 2025, by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to discover and develop GPR52 ligand probes as novel therapeutic candidates for cocaine use disorder (CUD). The University of Texas Medical Branch at Galveston will conduct basic and translational research to identify selective small molecule G protein-biased agonists targeting GPR52, a novel orphan G...
- The University of Pennsylvania received a $527,837 Project Grant award from the National Institute on Drug Abuse, part of the Department of Health and Human Services, to study altered midbrain GABAergic circuitry and its role in driving greater cocaine self-administration. Specifically, the researchers will characterize the functional state of midbrain GABAergic circuitry and the disposition of the KCC2 potassium-chloride cotransporter during cocaine self-administration, extinction, and...
- This five-year, $573,638 project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, supports research into the neural mechanisms of individual differences in cocaine avoidance. Funded under the Drug Abuse and Addiction Research Programs (CFDA 93.279), the grant to the Medical University of South Carolina will examine cellular mechanisms by which serotonin and glutamate receptors in the rostromedial tegmental nucleus drive aversive conditioning...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $800,131 to Boston Children's Hospital under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct basic neuroscience research examining the functions and mechanisms of a molecularly defined prefrontal cortex (PFC) neuron subtype in drug addiction. The award, initiated May 1, 2026, with completion anticipated February 28, 2031, supports a five-year investigation into how POU3F1-expressing...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $181,092 to Icahn School of Medicine at Mount Sinai, with an award date of May 1, 2026 and completion date of April 30, 2028, under the Drug Use and Addiction Research Programs (CFDA 93.279). This grant supports basic neuroscience research investigating the mechanisms by which dopamine receptor type 2 (D2)-expressing cells in the ventral hippocampus (VHPC) control relapse behavior in...
- The University of Washington was awarded a $149,284 Project Grant by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the role of specific subpopulations of prefrontal cortex pyramidal neurons in regulating drug-seeking behavior. The research aims to elucidate the factors that predispose individuals to addiction and confer vulnerability to relapse, with the goal of advancing understanding of the functional roles of...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $1,406,298 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through May 31, 2030. The award funds research examining nociceptin/orphanin FQ peptide (NOP) receptors as therapeutic targets for cocaine use disorder (CUD) treatment, addressing a significant public health gap where no FDA-approved medications...
- Federal Cooperative Agreement Summary The University of Chicago received a $1,010,328 Cooperative Agreement from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded April 15, 2026, with completion targeted for January 31, 2031. This research award funds an investigation into how social isolation during adolescence disrupts neurodevelopmental mechanisms that regulate addiction susceptibility. The research integrates behavioral...